Kai-Li Wang , Wei-Sen Gao , Abdul Nasir , Yuan-Fang Wang , Meng Yuan , Zhen-Zhen Zhang , Qian Bai , Zhi-Song Li
{"title":"Sleep deprivation modulates pain sensitivity through alterations in lncRNA and mRNA expression in the nucleus accumbens and ventral midbrain","authors":"Kai-Li Wang , Wei-Sen Gao , Abdul Nasir , Yuan-Fang Wang , Meng Yuan , Zhen-Zhen Zhang , Qian Bai , Zhi-Song Li","doi":"10.1016/j.neuropharm.2025.110485","DOIUrl":null,"url":null,"abstract":"<div><div>Sleep deprivation (SD) is a growing public health concern with implications for pain sensitivity and well-being. Although the relationship between sleep and pain is well understood, the underlying mechanisms remain largely unknown. This study investigates how SD influences pain sensitivity by modulating gene expression in the nucleus accumbens (NAc) and ventral tegmental area (VTA) of mice. Using the CPW sleep deprivation model, mice were deprived of sleep for three days, simulating preoperative conditions. Behavioral tests revealed heightened mechanical and thermal hypersensitivity post-SD. Brain MRI, immunofluorescence, and RNA sequencing analyses showed significant changes in the expression of non-coding RNAs (ncRNAs) and mRNAs in NAc and VTA, implicating several pain-related genes. Functional enrichment analysis highlighted pathways associated with neurotransmission, inflammation, and stress response. The study identified <em>Hcrt</em> and <em>Apoe</em> as critical modulators of SD-induced hyperalgesia, with potential therapeutic implications for managing pain associated with SD. Findings suggest that overlapping pathways exist between sleep and pain sensitivity, offering insights into the molecular mechanisms that connect sleep disorders with heightened pain responses.</div></div>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":"275 ","pages":"Article 110485"},"PeriodicalIF":4.6000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390825001911","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Sleep deprivation (SD) is a growing public health concern with implications for pain sensitivity and well-being. Although the relationship between sleep and pain is well understood, the underlying mechanisms remain largely unknown. This study investigates how SD influences pain sensitivity by modulating gene expression in the nucleus accumbens (NAc) and ventral tegmental area (VTA) of mice. Using the CPW sleep deprivation model, mice were deprived of sleep for three days, simulating preoperative conditions. Behavioral tests revealed heightened mechanical and thermal hypersensitivity post-SD. Brain MRI, immunofluorescence, and RNA sequencing analyses showed significant changes in the expression of non-coding RNAs (ncRNAs) and mRNAs in NAc and VTA, implicating several pain-related genes. Functional enrichment analysis highlighted pathways associated with neurotransmission, inflammation, and stress response. The study identified Hcrt and Apoe as critical modulators of SD-induced hyperalgesia, with potential therapeutic implications for managing pain associated with SD. Findings suggest that overlapping pathways exist between sleep and pain sensitivity, offering insights into the molecular mechanisms that connect sleep disorders with heightened pain responses.
期刊介绍:
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).